| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.060 | 3.551 | 3.696 | 2.707 | 2.842 | 7.693 | 0 | 32.905 | 126.561 | 130.873 |
| Total Income - EUR | 4.285 | 3.551 | 3.696 | 2.707 | 2.842 | 7.693 | 0 | 37.622 | 126.561 | 130.873 |
| Total Expenses - EUR | 7.142 | 6.078 | 2.412 | 4.234 | 3.333 | 17.109 | 15.557 | 58.990 | 135.077 | 155.635 |
| Gross Profit/Loss - EUR | -2.857 | -2.527 | 1.285 | -1.527 | -491 | -9.416 | -15.557 | -21.368 | -8.516 | -24.762 |
| Net Profit/Loss - EUR | -2.985 | -2.634 | 1.187 | -1.608 | -532 | -9.491 | -15.557 | -21.744 | -9.781 | -28.141 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 2 | 2 |
Check the financial reports for the company - Proline Sanmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.682 | 1.259 | 701 | 464 | 252 | 38.655 | 27.068 | 14.732 | 12.771 | 9.297 |
| Current Assets | 2.284 | 2.340 | 3.875 | 3.623 | 3.598 | 1.345 | 1.675 | 39.010 | 41.718 | 31.730 |
| Inventories | 1.358 | 1.346 | 1.083 | 0 | 0 | 437 | 427 | 30.876 | 30.821 | 25.079 |
| Receivables | 147 | 446 | 154 | 345 | 2.702 | 246 | 241 | 6.518 | 7.182 | 5.496 |
| Cash | 779 | 549 | 2.638 | 3.278 | 896 | 662 | 1.007 | 1.616 | 3.715 | 1.153 |
| Shareholders Funds | 6.144 | 3.447 | 4.576 | 2.883 | 2.296 | -7.231 | -22.627 | -46.784 | -56.424 | -84.249 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.822 | 152 | 0 | 1.204 | 1.554 | 47.231 | 51.369 | 100.527 | 110.912 | 125.276 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5920 - 5920" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Proline Sanmed Srl